Search Details

Word: biotech (lookup in dictionary) (lookup stats)
Dates: all
Sort By: most recent first (reverse)


Usage:

Unlike traditional medications, the brave new drugs will be designed "rationally" on computer screens, using gene information as a blueprint. VEGF2, for example, is a synthetic gene that makes a protein that in turn stimulates new vessel growth. In a few years, predicts William Haseltine, the biotech industry's champion optimist and CEO of Human Genome Sciences, based in Rockville, Md., we will have genetically based drugs for almost every serious ailment--"things we couldn't really work on well before, whether it's osteoporosis or Alzheimer's." Nor will these drugs simply attack symptoms, as aspirin does. "That...

Author: /time Magazine | Title: Got Any Good Drugs? | 11/8/1999 | See Source »

...Terminator isn't terminated just yet. Monsanto says it will press on with its attempted purchase of Delta (which is under federal antitrust review), and will use the technology to help with other biotech experiments. Meanwhile, the company says it will continue to investigate other ways to protect its copyrighted seeds ? without making your tomatoes barren...

Author: /time Magazine | Title: Monsanto Bows to a Biotech Backlash | 10/5/1999 | See Source »

...unfortunate agitation surrounding genetically modified foods. This tumult could be avoided if the public heard full and accurate discussion of the science supporting such foods. The Environmental Protection Agency, the Food and Drug Administration and the Department of Agriculture thoroughly review a full battery of studies before any biotech crop can be approved. A vast body of independent research confirms safety. As the co-director of the Food Allergy Research and Resource Program at the University of Nebraska, I feel comfortable eating any of the biotechnology products on shelves today. SUSAN HEFLE Lincoln...

Author: /time Magazine | Title: Letters: Oct. 4, 1999 | 10/4/1999 | See Source »

...Veteran's Day trip to Wall Street and the New York Stock Exchange. Among those speakers already confirmed are the founding partner of a billion-dollar venture capital firm and the former head of Harvard recruiting at Morgan Stanley, now chief financial officer at a Boston-based biotech firm...

Author: By Scott A. Resnick, CRIMSON STAFF WRITER | Title: A Worthy Investment: Wall Street in Harvard Square | 9/27/1999 | See Source »

...enhancing intellectual ability, some other personality trait changed as well? "Everything comes at a price," argues UCLA neurobiologist Alcino Silva. "Very often when there's a genetic change where we improve something, something else gets hit by it, so it's never a clean thing." The alarmists, like longtime biotech critic Jeremy Rifkin, go further. "How do you know you're not going to create a mental monster?" he asks. "We may be on the road to programming our own extinction...

Author: /time Magazine | Title: If We Have It, Do We Use It? | 9/13/1999 | See Source »

Previous | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 | 88 | 89 | 90 | 91 | 92 | 93 | 94 | 95 | 96 | 97 | 98 | Next